HTA - 12/67/01
Project title: Enzalutamide for the treatment of metastatic hormone relapsed prostate cancer previously treated with a docetaxel-containing regimen (ID600)
Call to action: 14/85 Batch 27
Research type: Evidence Synthesis
Chief investigator: Dr Rob Riemsma
[Image - ORCID logo]
Contractor: Kleijnen Systematic Reviews Ltd
Cost: £83,125.00
Started: June 2013 | Status: Project complete
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Why the research is being done and what is being asked
How the research is being done
What the research produced
What happened as a result of the research
© NIHR 2024